Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

United Therapeutics Corporation - Common Stock (NQ:UTHR)

306.97 -1.05 (-0.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 223,177
Open 309.58
Bid (Size) 295.12 (1)
Ask (Size) 314.59 (1)
Prev. Close 308.02
Today's Range 304.03 - 309.58
52wk Range 221.53 - 417.81
Shares Outstanding 44,891,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Reasons Investors Watch United Therapeutics (UTHR)
Over the last six months, United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% drop. This was partly due to its softer quarterly results... 
Via StockStory
Topics Stocks
Exposures US Equities
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks
Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-14.8%
-14.8%
1 Month
-3.7%
-3.7%
3 Month
-14.7%
-14.7%
6 Month
-14.4%
-14.4%
1 Year
+33.6%
+33.6%

More News

Read More
2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Earnings Scheduled For February 26, 2025
Via Benzinga
How Is The Market Feeling About United Therapeutics?
Via Benzinga
$1000 Invested In United Therapeutics 20 Years Ago Would Be Worth This Much Today
Via Benzinga
How Is The Market Feeling About United Therapeutics?
Via Benzinga
Evaluating UNITED THERAPEUTICS CORP (NASDAQ:UTHR) using Peter Lynch’s legendary strategy
Via Chartmill
2 Value Stocks on Our Watchlist and 1 to Ignore
Via StockStory
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025
From United Therapeutics Corporation
Via Business Wire
Why United Therapeutics (UTHR) Stock Is Down Today
Via StockStory
United Therapeutics (NASDAQ:UTHR) Reports Q4 In Line With Expectations
Via StockStory
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
From United Therapeutics Corporation
Via Business Wire
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings
Via StockStory
United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025
From United Therapeutics Corporation
Via Business Wire
United Therapeutics (UTHR): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
Topics Stocks
Exposures US Equities
United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress
From United Therapeutics Corporation
Via Business Wire
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Via Investor's Business Daily
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Announces Successful World’s First UKidney Transplant
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
From United Therapeutics Corporation
Via Business Wire

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?
Yes, United Therapeutics Corporation - Common Stock is publicly traded.
What exchange does United Therapeutics Corporation - Common Stock trade on?
United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for United Therapeutics Corporation - Common Stock?
The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
What is the current price of United Therapeutics Corporation - Common Stock?
The current price of United Therapeutics Corporation - Common Stock is 306.97
When was United Therapeutics Corporation - Common Stock last traded?
The last trade of United Therapeutics Corporation - Common Stock was at 03/28/25 04:00 PM ET
What is the market capitalization of United Therapeutics Corporation - Common Stock?
The market capitalization of United Therapeutics Corporation - Common Stock is 13.78B
How many shares of United Therapeutics Corporation - Common Stock are outstanding?
United Therapeutics Corporation - Common Stock has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.